Calmer Co wellness products surpasses 10k per day for March. Image: Getty.
Health & Biotech
Special Report: Health and wellness company The Calmer Co has reported a 25% increase in monthly online sales compared to February, with exponential growth in the sector since April last year.
The Calmer Co (ASX:CCO) is riding a burgeoning trend of people under 30 not drinking alcohol linked to a boom in healthy lifestyles.
With Millennials and Gen Z driving the mindful drinking movement ‘NoLo’ (no and low alcohol), demand is on the rise.
The company produces a range of Fiji-produced kava beverages – including its Taki Mai products that have recently hit stores in Coles supermarkets.
CCO has been hard at work digitising its supply chain from eight major kava-producing provinces in Fiji and will be rolling out consumer functionality throughout 2024 on top of its other already implemented eCommerce growth platforms.
The company has also fully relocated its 40,000ft processing centre in Navua on Fiji’s main island of Viti Levu and is increasing drying, milling and sieving capacity, as well as automating packaging and labelling processes to meet increased demand.
Despite shipping delays into Australia during January and February, eCommerce sales of CCO products have snowballed, mitigated by a material uplift in March sales of >$320,000.
eCommerce sales growth from April last year to the end of March 2024. Pic supplied: (CCO)
With now >$10,000/month in eCommerce sales per month, CCO sees major growth in increasing its online market exposure.
Calmer Co CEO Anthony Noble says eCommerce remains the company’s first growth pillar.
“We have added Walmart.com to our successful Amazon.com platform and are now focusing on Shopify on www.fijikava.com in the USA, which will build on the proven effective methodologies we have been using in the Australian market via the Meta channels (Facebook and Instagram) driven through the Shopify platform,” Noble says.
“We also have received a high level of consumer engagement with the launch of our Taki Mai kava shots into Coles in Australia in March, and we are working on some new innovative product formats to support both retail and online sales growth over the coming quarter, which we believe will fuel further increased sales velocity in all channels.”
This article was developed in collaboration with Calmer Co, a Stockhead advertiser at the time of publishing.
This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.
Health & Biotech
Health & Biotech
Health & Biotech
